People and preparation
Map staff competencies, specimen preparation, staining, acquisition and supervision needs.
Investors & partners
Build the capacity
care depends on.
Kebeza is building a pathology service model around local laboratories, shared specialist expertise and acquisition that fits the setting. Choose the work you can help move forward.
PathEdge: founder-fundedPre-revenue · In development
For investors
The unit is an accountable
completed diagnostic case.
Referring clinics, laboratories and hospital networks are the intended buyers. They buy access to a completed case with qualified review and an accountable report.
New specimens create recurring demand for diagnostic support. Software, acquisition tools and workforce organisation are the means of delivering that service.
Why this team
Dr Sharrif Musoke is a practising pathologist in Uganda’s national referral system and leads pathology resident training at Mulago National Referral Hospital, Uganda. Regional clinical work has supplied practical lessons about preparation, staffing, review and patient access.
Revenue unitCompleted diagnostic case
Paid for by the referring organisation under a service arrangement to be evaluated.
Costs to includeThe whole delivery pathway
Preparation, acquisition, specialist time, equipment, training, support and quality assurance.
Measures to establishCapacity, quality and contribution
Cases per cytotechnologist-hour and pathologist-hour, site cost, turnaround, major discrepancy rate and contribution per case.
What investment would help establish
- Repeatable service delivery
Evaluate site onboarding, acquisition quality and supervised review through complete cases.
- Evidence and economics
Measure clinical discrepancies, specialist time, support costs and willingness to pay.
- Responsible expansion
Use the results to decide which settings and acquisition methods can support repeatable paid service.
The next commercial tests are pricing, repeat paid demand and contribution per completed case. Historical clinical service is distinct from platform traction.
For clinical & institutional partners
Bring a real workflow.
Define an evaluation together.
For hospitals, laboratories, regional clinics and organisations planning diagnostic outreach.
Start with the specimen pathway, available staff and equipment, reporting responsibilities and the patients the site serves. Agree a scoped evaluation before making a service commitment.
Prefer email? Discuss your settingReview and accountability
Agree who screens, reviews, escalates and signs out, including discrepancy handling and patient communication.
Evaluation outputs
A workflow map, training and supervision plan, capture-quality record, timing study and cost review.
Patient appointments use a separate entrance.
If you need care, services or a result-status check, go to patient access. Evaluation enquiries reach the Kebeza office.
For research & grant partners
Fund the questions
that practice needs answered.
Proposed work packages for independent validation, subject to institutional and ethics approvals and funding.
Competency and supervision
Define acquisition and screening competencies, supervised assessments and refresher-training requirements.
DeliverableCompetency framework and supervised performance record.
Image and glass-slide review
Retrieve historical records and available images/slides; plan blinded rereads with a second independent pathologist and histology correlation where available.
DeliverableAuditable case set and discrepancy analysis under an approved protocol.
Pathway feasibility
Evaluate same-day cytology, routine histology pathways and affordable acquisition reliability in defined settings.
DeliverableTiming, quality, repeat-capture and cost measures.
Registries and cervical studies
Develop permissioned image-registry work, HPV self-collection validation and p16/Ki-67 triage proposals.
DeliverableProtocols, data-governance agreements and a study-specific evaluation plan.
Proposed institutional leadership.
Mulago is the proposed research lead, with Dr Sharrif Musoke as proposed principal investigator. Clinics and cytotechnologists are prospective collaborators. Kebeza’s proposed role is technical and service implementation. Roles and agreements will be settled through the study protocol.
Clinical records do not enter research or external models automatically. Consent or another legal basis, ethics review, access controls, de-identification and institutional agreements apply. Patient data are not offered for sale.
For technology partners
Make the next tool
work in a real laboratory.
Acquisition
Microscope cameras, existing scanners, systematic mosaicking and affordable automated retrofits. Evaluate coverage, focus, colour and repeatability.
Compute and evaluation
Explore compute or API support for acquisition-quality checks, documentation and model evaluation. Diagnostic AI needs a separate validation pathway.
Language and access
Improve multilingual navigation and integration with local services. Sunbird integration is in development.
We are seeking technical support for defined evaluations.
Start with the work
Tell us the setting.
We’ll discuss the next step.
Include your organisation, the pathway or work package you have in mind, available equipment or expertise, and the question you want to answer.
kebezahealth@gmail.com